2024
DOI: 10.1016/j.jacadv.2023.100743
|View full text |Cite
|
Sign up to set email alerts
|

Underrepresentation of Women in Reduced Ejection Heart Failure Clinical Trials With Improved Mortality or Hospitalization

Eson Ekpo,
Sujana Balla,
Summer Ngo
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 57 publications
0
3
0
Order By: Relevance
“…Another limitation is that many participants are not heavily involved in HF care in terms of patient volume, and thus in specialty care the picture could be different. We did not inquire on possible perceived gender differences in the management of HF patients, and this should be further investigated whether physicians apply GDMT differently depending on their own and patients and physician gender ( 53 , 54 ). Finally, this only refers to clinical practice in Sweden up to 2021–2022 and might not be generalizable to other settings.…”
Section: Discussionmentioning
confidence: 99%
“…Another limitation is that many participants are not heavily involved in HF care in terms of patient volume, and thus in specialty care the picture could be different. We did not inquire on possible perceived gender differences in the management of HF patients, and this should be further investigated whether physicians apply GDMT differently depending on their own and patients and physician gender ( 53 , 54 ). Finally, this only refers to clinical practice in Sweden up to 2021–2022 and might not be generalizable to other settings.…”
Section: Discussionmentioning
confidence: 99%
“…In conclusion, the study by Ekpo et al 4 serves as a wake-up call to the medical research community about the ongoing sex disparity in HF clinical trials. While the problem is clear, the solutions require concerted efforts from all stakeholders, including researchers, industry sponsors, and regulatory bodies.…”
mentioning
confidence: 92%
“…In this issue of JACC: Advances , Ekpo et al 4 present a thought-provoking study that adds to the growing body of evidence indicating that women are underrepresented in HF clinical trials. In their analysis, they specifically included HF clinical trials that observed mortality or hospitalization for HF, and they mirrored the timeline used by the 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America Guidelines for the Management of Heart Failure, 5 which included studies that were published through September 2021.…”
mentioning
confidence: 99%